Citation

Moresco L, Bellissima V, Colivicchi M, Crivelli S, Guerriero F, Ricotti A, Sabatini M, Strozzi MC, Temporini F, Gazzolo D. Minerva Pediatr. 2010; 62(3 Suppl 1): 141-143.

Vernacular Title

Markers of brain injury in non-invasive biological fluids.

Affiliation

Department of Fetal, Maternal and Neonatal Medicine, C. Armgo, Alessandria, Italy.

Copyright

(Copyright © 2010, Edizioni Minerva Medica)

DOI

unavailable

PMID

21090084

Abstract

Hypoxia-ischemia (H-I) constitutes the main phenomenon responsible for brain-blood barrier permeability modifications leading to cerebral vascular autoregulation loss in newborns. Hypotension, cerebral ischemia, and reperfusion are the main events involved in vascular auto-regulation loss leading to cell death and tissue damage. Reperfusion could be critical since organ damage, particularly of the brain, may be amplified during this period. An exaggerated activation of vasoactive agents, of calcium mediated effects could be responsible for reperfusion injury (R-I), which, in turns, leads to cerebral hemorrhage and damage. These phenomena represent a common repertoire in newborns complicated by perinatal acute or chronic hypoxia treated by risky procedures such as mechanical ventilation, nitric oxide supplementation, brain cooling, and extracorporeal membrane oxygenation (ECMO). Despite accurate monitoring, the post-insult period is crucial, as clinical symptoms and standard monitoring parameters may be silent at a time when brain damage is already occurring and the therapeutic window for pharmacological intervention is limited. Therefore, the measurement of circulating biochemical markers of brain damage, such as vasoactive agents and nervous tissue peptides is eagerly awaited in clinical practice to detect high risk newborns. The present article is aimed at investigating the role of dosage biochemical markers in non-invasive biological fluids such as S100B, a calcium binding protein, activin A, a protein expressed in Central nervous System (CNS).

Language: it